Study: 2/3 Diabetics Not Hitting Targets
Posted on: Wednesday, 12 April 2006, 15:00 CDT
A new global study released Wednesday showed that about two-thirds of type 2 diabetics are not hitting target blood-sugar levels.
Notably, the survey revealed a fairly widespread fear of taking what is considered the gold-standard treatment for the disease, insulin.
According to the OPTIMISE (Obtaining Control in Diabetes) study of 1,500 type 2 diabetics in seven countries, 64 percent of those surveyed were not consistently achieving their optimal blood-sugar levels over a 10-year period.
The study revealed that 55 percent of those taking insulin for their condition fell short of their targets, while 69 percent of diabetics taking oral tablets to treat the disease failed to meet their goals.
The polling further showed that, of type 2 diabetics controlling the condition with oral pills and/or diet and exercise, almost half said they would avoid insulin even if it was recommended by a physician.
Another 13 percent said they would be apprehensive about taking insulin. This hesitancy to take insulin was apparent in all of the countries in which the polling was conducted, regardless of whether syringes or the newer insulin-delivering pens were widely available, the researchers said.
Most diabetics surveyed who were fearful of the treatment cited injection-related factors as the basis for their worries.
Overall, the survey showed that the overwhelming majority of people with diabetes wish there (were) another way to take insulin, the researchers said.
These findings are really very worrying, said an official with the International Diabetes Foundation. It is vital that we address why people are not getting to target (blood sugar) levels, in order to reduce the growing incidence of the devastating complications associated with diabetes.
Complications include blindness, kidney failure, amputations and heart attack.
The World Health Organization estimates that 366 million people will have the disease in the next 25 years.
Source: United Press International
Related Articles
- Surveyed Neurologists in Both the United States and Europe Indicate That a Once-Daily Transdermal Formulation of Levodopa Would Earn a 30 Percent Patient Share in Parkinson's Disease
- Diabetes Significantly Increases Risk for Alzheimer's Disease and Other Dementia
- MannKind Reports Positive Data From a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
- Incyte's Selective Oral Inhibitor of 11beta-HSD1 Demonstrates Improvements in Insulin Sensitivity and Lowers Cholesterol Levels in Type 2 Diabetics
- El Camino Hospital Again Ranks Among Top Five Percent in Nation According to HealthGrades Quality Study
- Oxidative Stress in Diseases is Studied
- Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
- Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin; 80 Percent of Diabetes Patients in Study Preferred Inhaled Insulin System to Mealtime Injections
- Infections of Febrile Neutropenic Patients in Malignant Hematological Diseases (Second Study Period)
- Insulin Seen Possible Diabetes Trigger
 |
 |
User Comments (0)
RSS Feeds